Profile for Slovenia Patent: 2639234
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Slovenia Patent: 2639234
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Nov 11, 2031 | Bdsi | SYMPROIC | naldemedine tosylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
